Publication | Closed Access
Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
10
Citations
0
References
2016
Year
Finally, although the study of the mechanisms of action of these compounds is still unsolved, many reports and patents strongly suggest therapeutic potential of these compounds in neurological diseases.